Wells Fargo upgrades Albany Molecular Research (Nasdaq: AMRI) from 'Market Perform' to 'Outperform' while maintaining a valuation range of $7-$9 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE